AVH ASX Chart
Snapshot
AVITA Medical, Inc (AVH, formerly AVITA Therapeutics, Inc.) is a commercial-stage regenerative medicine company transforming the standard of care in wound care management and skin restoration with innovative devices. At the forefront of our platform is the RECELL System, approved by the Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -15.83% |
vs ASX 200 (1yr) | -17.65% |
Announcements
Corporate Overview
Corporate Details
Head Office | Valencia CA USA 91355 |
Website | www.avitamedical.com |
Registry | Computershare |
Auditor | Grant Thornton LLP |
Date Listed | 11 Aug 1993 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
21/02/2025 | Report (Prelim) |
21/02/2025 | Report (Annual) |
23/04/2025 | Report (Annual) |
08/08/2025 | Report (Interim) |
Former Company Names
- AVITA Therapeutics, Inc. (AVH), 20/01/2021
- Avita Medical Ltd (AVH), 30/06/2020
- Greenchip Resources Limited (GRC), 31/08/1999. Clinical Cell Culture Limited (CCE), 25/06/2008
- Ecat Development Capital Limited (ECL), 11/11/2002
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
AVH directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of AVH directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
The Vanguard Group, Inc | 31/01/2024 | 1,392,780 | 5.42 |
BlackRock Institutional Trust Company NA | 31/01/2024 | 1,806,149 | 7.03 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $2.42 | 28 June |
2023 | $5.19 | 30 June |
2022 | $1.39 | 30 June |
2021 | $5.23 | 30 June |
2020 | $9.00 | 30 June |
2019 | $0.42 | 28 June |
2018 | $0.069 | 29 June |
2017 | $0.077 | 30 June |
2016 | $0.092 | 30 June |
2015 | $0.072 | 30 June |
2014 | $0.10 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.